Dysregulated splicing of FGFR2 contributes to tumor progression in multiple cancers, including gastric carcinoma and cholangiocarcinoma, where differential isoform expression influences both tumor growth and metastatic behavior111,.112. Here, FGFR2 is linked to cholangiocarcinoma.